MedTrace Logo

Acute Effects of Menthol Gargle and Buccal Film on Anaerobic Capacity and Respiratory Parameters in Male Volleyball Players

NCT07745049 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2026-08-04

No results posted yet for this study

Summary

Menthol activates the transient receptor potential melastatin 8 (TRPM8) channel and can alter thermal and respiratory perception without producing an actual reduction in body or tissue temperature. Evidence on whether oral menthol improves short-duration maximal (anaerobic) performance is limited and inconsistent, and almost all existing exercise studies have delivered menthol as a mouth rinse, solution, gel or topical preparation. A menthol-containing buccal film represents a distinct route of oral administration, because it adheres to the buccal mucosa and may alter the residence time and release profile of menthol in the oral cavity. No controlled exercise study has compared a menthol-containing buccal film with menthol mouth-rinsing and a placebo condition in athletes.

This single-blind, randomized, three-condition crossover trial compares the acute effects of a placebo (water control), menthol mouth-rinsing, and a menthol-containing buccal film on anaerobic performance in male volleyball players. The primary outcome is anaerobic performance measured with the 30-second Wingate Anaerobic Power Test. Secondary (exploratory) outcomes are respiratory function assessed by spirometry, post-exercise blood lactate concentration, and post-exercise plasma hypoxia-inducible factor-1 alpha (HIF-1alpha) concentration.

Each participant completes all three conditions in a randomized order, separated by 72-hour washout periods. Both active conditions deliver a standardized total of 10 mg of L-menthol.

All testing sessions are conducted at the same time of day, under similar environmental conditions, and by the same researcher.

Conditions

  • Menthol

Interventions

OTHER

Placebo (water control)

40 mL of tap water administered as two 20 mL volumes; each rinsed for 30 seconds and expectorated without swallowing.

OTHER

Menthol gargle

40 mL of aqueous solution containing 10 mg L-menthol (0.025% w/v), administered as two 20 mL volumes; each rinsed for 30 seconds and expectorated without swallowing.

OTHER

Menthol buccal film

Buccal film containing 10 mg L-menthol, applied to the buccal mucosa.

Sponsors & Collaborators

  • Vedat Cinar

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-25
Primary Completion
2026-01-02
Completion
2026-01-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07745049 on ClinicalTrials.gov